Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research II1 Apr 2015MP47-12 MIR-646 IN CLEAR CELL RENAL CARCINOMA CORRELATED WITH TUMOUR METASTASIS BY TARGETING THE NIN ONE BINDING PROTEIN Wei Li, Yuanyuan Zhang, Min Liu, Jianping Che, and Junhua Zheng Wei LiWei Li More articles by this author , Yuanyuan ZhangYuanyuan Zhang More articles by this author , Min LiuMin Liu More articles by this author , Jianping CheJianping Che More articles by this author , and Junhua ZhengJunhua Zheng More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.1532AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Renal cell carcinoma (RCC) is a common urologic malignancy and accounts for 3% of adult malignancies and causes 90 000 deaths worldwide annually. Biomarkers for early detection and followup of the disease are not available at present. Previous studies have found that nin one binding protein (NOB1) was identified as a potential oncogene in human glioma and miR-646 plays an important role in human growth and development. However, the underlying molecular mechanisms of NOB1 in tumorigenicity and its correlation with miR-646 in renal cell carcinoma (RCC) have not been investigated. METHODS We performed bioinformatic analysis to explore miRNA targeting NOB1. The expression of NOB1 and miR-646 from 100 cases of clear cell RCC (ccRCC) and 30 cases of adjacent non-tumour tissues were detected by quantitative real-time PCR. The expression of miR-646 was correlated with NOB1 expression, tumour features and patient metastasis-free survival. The effect of overexpression of mir-646 on renal cancer cell proliferation was detected by colony formation in soft agar. Using a xenograft tumour model, we observed the in vivo tumorigenesis effect of miR-646 and NOB1. RESULTS miR-646 negatively regulated NOB1 and inhibited the proliferation and migration of renal cancer cells. There was a significant upregulation of NOB1 in ccRCC and it was further increased in metastatic cases, while miR-646 was downregulated in tumour tissues and further decreased in metastatic ccRCC. Additionally, expression of miR-646 was inversely correlated with the expression of NOB1. The downregulation of miR-646 also indicated a higher probability of developing metastasis. Most importantly, miR-646 expression was an independent predictor of ccRCC metastasis by the univariate analysis and binary logistic regression model (both P≤0.05). Colony formation in soft agar and xenograft tumour model suggested that miR-646 and NOB1 are required for tumorigenesis in vitro and in vivo. Furthermore, suppression of NOB1 increased the phosphorylation of several proteins in MAPK pathway. CONCLUSIONS Our findings suggest that NOB1 as a novel target of miR-646. Overexpression of miR-646 decreased tumorigenesis of renal cancer cells through the modulation of MAPK pathway. Clinically, NOB1 expression might be associated with tumour grade as well as the prognosis of ccRCC. Our findings suggest that exogenous overexpression of miR-646 may be considered as a promising strategy for targeted therapies in renal cancer. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e556 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Wei Li More articles by this author Yuanyuan Zhang More articles by this author Min Liu More articles by this author Jianping Che More articles by this author Junhua Zheng More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

The Role of Nephroblastoma Overexpressed Gene on Renal Cell Carcinoma

NOV Modulates Expression of MMP in Clear Cell Renal Cell Carcinoma

Nephroblastoma Overexpressed Gene (NOV) Enhances RCC Cell Motility Through Upregulation of ICAM-1 and COX-2 Expression Via Akt Pathway.

Nephroblastoma Overexpressed Protein (NOV) Enhances 5-Fu-mediated Inhibitory Effect of Colorectal Cancer Cell Proliferation Via JNK/AP-1/caspase-8/caspase-3 Pathway

Effects of Nephroblastoma Overexpressed Gene on Proliferation and Differentiation of Neural Stem Cells in Rats

Effects of Heterogously- Expressed RON Receptor Tyrosine Kinase on Motile/invasive Ability of Human Colorectal Cancer Cell Line RKO

Effect of NUP88 gene on proliferation and invasion biological behavior of breast cancer cell line BT-20

Reduced NOV Expression Correlates with Disease Progression in Colorectal Cancer and is Associated with Survival, Invasion and Chemoresistance of Cancer Cells

A Novel Function of NUCB2 in Promoting the Development and Invasion of Renal Cell Carcinoma

Amino-truncated NOV expression and its correlation with clinicopathologic features, prognosis, metastasis, and chemoresistance in bladder cancer

Influences of Over-Expression of VEGF-C and Its Inhibition on Biological Characteristics of NCI-H446 Human Small-Cell Lung Cancer Cells

High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.

Downregulated Mir-646 in Clear Cell Renal Carcinoma Correlated with Tumour Metastasis by Targeting the Nin One Binding Protein (NOB1)

Effect of NOK Over-expression on Proliferation of Lung Adenocarcinoma Cell A549

Lentivirus-mediated Nrp1 overexpression promotes the proliferation of ovarian cancer cells

Oncogenic Role of NUPR1 in Ovarian Cancer

Effects of Fibroblasts on the Proliferation and Migratory Capacity of Renal Cell Carcinoma Cell Lines and Sensitivity to Everolimus

MP47-12 MIR-646 IN CLEAR CELL RENAL CARCINOMA CORRELATED WITH TUMOUR METASTASIS BY TARGETING THE NIN ONE BINDING PROTEIN

Up-Regulation Of Pvhl Along With Down-Regulation Of Hif-L Alpha By Ndrg2 Expression Attenuates Proliferation And Invasion In Renal Cancer Cells

Differential Expression of CCN Family Members CYR611, CTGF and NOV in Gastric Cancer and Their Association with Disease Progression

Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)